Publications by authors named "Dinshaw L"

Article Synopsis
  • Non-vitamin-K oral anticoagulants like Edoxaban are effective for preventing strokes in patients with atrial fibrillation (AF), but there's limited data on their long-term outcomes in routine care in Germany, Austria, and Switzerland (DACH).
  • The ETNA-AF-Europe study enrolled 13,092 AF patients across 10 European countries, with 5,457 patients from the DACH region, revealing that the majority received appropriate Edoxaban dosing.
  • After one year, the study found low rates of stroke (0.8%/year) and severe bleeding (0.7%/year), but higher age and frailty were linked to increased mortality and complications.
View Article and Find Full Text PDF

Background: Despite advances in efficacy and safety of pulmonary vein isolation (PVI), atrial fibrillation (AF) recurrence after PVI remains common. PV-reconnection is the main finding during repeat PVI procedures performed to treat recurrent AF.

Objective: To analyze pulmonary vein (PV) reconnection patterns during repeat ablation procedures in a large cohort of consecutive patients undergoing radio frequency or cryoballoon-based PVI.

View Article and Find Full Text PDF

Background: Electrographic flow (EGF) mapping enables full spatiotemporal reconstruction of organized wavefront propagation to identify extrapulmonary vein sources of atrial fibrillation (AF).

Objectives: FLOW-AF (A Randomized Controlled Study to Evaluate the Reliability of the Ablacon Electrographic FLOW [EGF] Algorithm Technology [Ablamap Software] to Identify AF Sources and Guide Ablation Therapy in Patients With Persistent Atrial Fibrillation) was multicenter, randomized controlled study of EGF mapping to: 1) stratify a nonparoxysmal AF population undergoing redo ablation; 2) guide ablation of these extrapulmonary vein AF sources; and 3) improve AF recurrence outcomes.

Methods: FLOW-AF enrolled persistent atrial fibrillation (PerAF)/long-standing PerAF patients undergoing redo ablation at 4 centers.

View Article and Find Full Text PDF
Article Synopsis
  • Electrographic flow (EGF) mapping detects active sources of atrial fibrillation (AF) outside the pulmonary veins, aiming to improve classification and treatment of persistent AF based on its underlying causes.
  • The FLOW-AF trial will assess the accuracy of EGF mapping using Ablamap software to identify AF sources in patients with persistent AF who have not had success with previous pulmonary vein isolation.
  • The study involves 85 participants who will be randomly assigned to receive either just pulmonary vein isolation or both pulmonary vein isolation and targeted ablation of identified extravascular AF sources, focusing on safety and effectiveness outcomes.
View Article and Find Full Text PDF

Background: A novel multielectrode radiofrequency balloon (RFB) catheter has been released for pulmonary vein isolation (PVI).

Methods and results: In this observational study consecutive patients with drug-refractory paroxysmal or persistent atrial fibrillation (AF) undergoing first-time PVI were enrolled in 2 high-volume ablation centers. All procedures were conducted in conjunction with a 3D-mapping system.

View Article and Find Full Text PDF

Purpose: Pulsed-field ablation (PFA) is a new energy source to achieve pulmonary vein isolation (PVI) by targeted electroporation of cardiomyocytes. Experimental and controlled clinical trial data suggest good efficacy of PFA-based PVI. We aimed to assess efficacy, safety and follow-up of PFA-based PVI in an early adopter routine care setting.

View Article and Find Full Text PDF

Background: Hybrid activation mapping is a novel tool to correct for spatial displacement of the mapping catheter due to asymmetrical contraction of myocardium during premature ventricular contractions (PVC). The aim of this study is to describe and improve our understanding of spatial displacement during PVC mapping as well as options for correction using hybrid activation mapping.

Methods And Results: We analyzed 5798 hybrid mapping points in 40 acquired hybrid maps of 22 consecutive patients (age 63 ± 16 years, 45% female) treated for premature ventricular contractions (PVCs).

View Article and Find Full Text PDF

Background: Despite continued efforts to improve the safety of catheter ablation, pericardial tamponade remains one of its more frequent, potentially life-threatening complications. Management of cardiac tamponade is not standardized and uncertainties regarding acute treatment remain.

Methods: This survey sought to evaluate the management of cardiac tamponade in German EP centers via a standardized postal questionnaire.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared the outcomes of ventricular tachycardia (VT) ablation using ultra-high-density (UHD) mapping versus traditional point-by-point 3D mapping in 122 patients (61 in each group).
  • Results showed that patients guided by UHD mapping had a significantly lower 24-month rate of VT recurrence or disease-related death (52.4%) compared to those using conventional mapping (69.6%).
  • Both mapping techniques had similar complication rates and procedural parameters, but UHD mapping was linked to better long-term outcomes and was identified as a factor for reduced recurrence or mortality.
View Article and Find Full Text PDF

Pulmonary vein (PV) isolation (PVI) by continuous, transmural and durable lesions is decisive for ensuring long-term freedom from atrial fibrillation (AF). AF ablation requires irrigated tip catheters to reduce thromboembolic complications. This precluded temperature-controlled delivery of radiofrequency (RF) energy.

View Article and Find Full Text PDF

Background EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) demonstrated clinical benefit of early rhythm-control therapy (ERC) in patients with new-onset atrial fibrillation (AF) and concomitant cardiovascular conditions compared with current guideline-based practice. This study aimed to evaluate the generalizability of EAST-AFNET 4 in routine practice. Methods and Results Using a US administrative database, we identified 109 739 patients with newly diagnosed AF during the enrollment period of EAST-AFNET 4.

View Article and Find Full Text PDF
Article Synopsis
  • Bipolar radiofrequency ablation (B-RFA) is a treatment for heart problems when other therapies don't work.
  • A study found it was effective in many patients with serious heart issues, and most had good results after the treatment.
  • Combining different types of B-RFA techniques helped make bigger lesions, which is better for treatment, but some complications can happen.
View Article and Find Full Text PDF

Introduction: Cryoballoon (CB) ablation for pulmonary vein isolation (PVI) is an effective treatment of atrial fibrillation (AF). Recently, a novel cryoablation system was introduced. The aim of the study was to compare the safety, efficacy and biophysical characteristics of a novel cryoablation system (POLARx™; Boston Scientific) to a commonly used and clinically well characterized system (Arctic Front Advance Pro™, AFA; Medtronic).

View Article and Find Full Text PDF

We report the case of an 80-year-old female presenting with polymorphic premature ventricular contractions, nonischemic cardiomyopathy, and severe, secondary mitral regurgitation. Despite a low intraprocedural PVC burden, activation mapping and successful ablation of different morphologies were achieved using a novel mapping tool, which facilitates simultaneous mapping of different PVC morphologies.

View Article and Find Full Text PDF

Purpose: Recently, a novel cardiac imaging system based on a wide-band dielectric technology (KODEX-EPD) was introduced to guide catheter ablation. The aim of the study was to evaluate this 3D wide-band dielectric imaging system (WDIS) during cryoballoon (CB)-based atrial fibrillation (AF) ablation focusing on accuracy of pulmonary vein (PV)-anatomy.

Methods: In consecutive patients with symptomatic AF, CB-based ablation was performed in conjunction with the 3D WDIS.

View Article and Find Full Text PDF

Background Atrial fibrillation (AF) is common in patients with hypertrophic cardiomyopathy (HCM) and is associated with a deterioration of clinical status. Ablation of symptomatic AF is an established therapy, but in HCM, the characteristics of recurrent atrial arrhythmias and the long-term outcome are uncertain. Methods and Results Sixty-five patients with HCM (aged 64.

View Article and Find Full Text PDF

Introduction: Substrate-based catheter ablation approaches to ventricular tachycardia (VT) focus on low-voltage areas and abnormal electrograms. However, specific electrogram characteristics in sinus rhythm are not clearly defined and can be subject to variable interpretation. We analyzed the potential ablation target size using automatic abnormal electrogram detection and studied findings during substrate mapping in the VT isthmus area.

View Article and Find Full Text PDF

Introduction: Tailored catheter ablation of atrial tachycardias (ATs) is increasingly recommended as a potentially easy treatment strategy in the era of high-density mapping (HDM). As follow-up data are sparse, we here report outcomes after HDM-guided ablation of ATs in patients with prior catheter ablation or cardiac surgery.

Methods And Results: In 250 consecutive patients (age 66.

View Article and Find Full Text PDF

Purpose Of Review: Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated.

View Article and Find Full Text PDF